Scholarlink

Introduction <p>Global demand for the treatment of cannabis use disorder has increased significantly, prompting a need to understand effective strategies for addressing concurrent cannabis and tobacco use. This study focuses on clinicians' experiences and perceptions in delivering tobacco cessation services to people who use cannabis.</p> Methods <p>Fifteen participants (12 females, 3 males) participated in three homogenous focus groups, including two groups with extensive experience in providing tobacco cessation among the substance use population in Catalonia, Spain, and one group of clinicians without such experience. Thematic analysis was conducted to identify key patterns and insights in their discourse, focusing on shared themes and divergences across groups.</p> Results <p>Five main themes and 17 subthemes emerged: Individual characteristics, Clinician characteristics, Models of intervention, Organizational healthcare models, and Health policies. Clinicians stressed the importance of intervention models and the active role of professionals in addressing tobacco use within routine care, as tobacco cessation could mitigate social and chronic stigma among people who use cannabis, especially those engaged in polydrug use.</p> Discussion and conclusions <p>Recommendations included integrating tobacco cessation into all services, reducing healthcare service fragmentation, improving resource accessibility, enhancing clinical documentation, and advocating for stronger population-level tobacco control policies.</p> Trial registration <p>The ACT-ATAC project has been successfully registered at Clinicaltrials.gov [NCT04841655].</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinician’s perceptions and experiences with tobacco treatment in people who use cannabis: a qualitative study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年1月21日

查看全文
  • Cristina Martínez,
  • Marga Pla,
  • Ariadna Feliu,
  • Marta Enríquez,
  • Judith Saura,
  • Carmen Cabezas,
  • Joan Colom,
  • Josep M. Suelves,
  • Sílvia Mondon,
  • Pablo Barrio,
  • Magalí Andreu,
  • Antònia Raich,
  • Jordi Bernabeu,
  • Xavier Roca,
  • Maite Narváez,
  • Esteve Fernández,
  • Laia Miquel,
  • Pol Bruguera,
  • Karen Nadal,
  • Monika Anduaga,
  • Silvia Martínez,
  • Beth Pallejà,
  • Rosanna Reyes,
  • Enrique Surribas,
  • Francina Fonseca,
  • Clara Caterina,
  • Diego Aranega,
  • Nuria Cabezón,
  • Víctor Martí,
  • Amalia Gual,
  • Carolina Franco,
  • Delia Parellada,
  • Laura Masferrer,
  • Esther Batllori

摘要

Introduction

Global demand for the treatment of cannabis use disorder has increased significantly, prompting a need to understand effective strategies for addressing concurrent cannabis and tobacco use. This study focuses on clinicians' experiences and perceptions in delivering tobacco cessation services to people who use cannabis.

Methods

Fifteen participants (12 females, 3 males) participated in three homogenous focus groups, including two groups with extensive experience in providing tobacco cessation among the substance use population in Catalonia, Spain, and one group of clinicians without such experience. Thematic analysis was conducted to identify key patterns and insights in their discourse, focusing on shared themes and divergences across groups.

Results

Five main themes and 17 subthemes emerged: Individual characteristics, Clinician characteristics, Models of intervention, Organizational healthcare models, and Health policies. Clinicians stressed the importance of intervention models and the active role of professionals in addressing tobacco use within routine care, as tobacco cessation could mitigate social and chronic stigma among people who use cannabis, especially those engaged in polydrug use.

Discussion and conclusions

Recommendations included integrating tobacco cessation into all services, reducing healthcare service fragmentation, improving resource accessibility, enhancing clinical documentation, and advocating for stronger population-level tobacco control policies.

Trial registration

The ACT-ATAC project has been successfully registered at Clinicaltrials.gov [NCT04841655].